Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or Myeloma

Clinical trial NCT00276536 · COMPLETED

Trial details

NCT number: NCT00276536
Sponsor: The Cleveland Clinic
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Cancer Kidney Cancer Lymphoma Melanoma Multiple Myeloma Sarcoma Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2001-01-01
Primary completion: 2004-01-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.